Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
about
Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemiaProkaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technologyProtein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.Flt3-ITD mutations can generate leukaemia specific neoepitopes: potential role for immunotherapeutic approaches.Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.
P2860
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
@ast
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
@en
type
label
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
@ast
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
@en
prefLabel
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
@ast
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
@en
P2093
P2860
P1476
Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans
@en
P2093
Marie Robin
Marie-Hélène Schlageter
Rose-Ann Padua
P2860
P2888
P304
P356
10.1007/S00262-005-0678-1
P577
2005-05-12T00:00:00Z